Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-B3 (PCDHGB3) is a member of the protocadherin gamma gene cluster, which encodes neural cadherin-like cell adhesion proteins thought to play a critical role in establishing and maintaining specific cell-cell connections in the brain. This protein is a potential calcium-dependent cell adhesion molecule, with its extracellular region composed of six cadherin ectodomains and a transmembrane domain, followed by a shared cytoplasmic domain. PCDHGB3 is primarily expressed in neural tissues and may be involved in guiding neuronal network formation and synaptic specificity. Alternative splicing has been reported for the gene, contributing to its functional diversity within the nervous system. Not considered a classic therapeutic target (not a receptor, enzyme, transporter, etc.), but may be relevant in neurodevelopmental disorders. No known drugs, mechanisms of action, or biomarkers are reported for this protein in the context of pharmacological targeting. The primary function relates to neural cell adhesion and brain development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-B3 (PCDHGB3).